Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Medigene AG. (7/10/14). "Press Release: Medigene AG Confirms Final Subscription Price for New Shares and Final Conversion Price for Convertible Bonds [Not for release, publication or distribution in the United States, Canada, Japan or Australia]". Martin

Organisation Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
Products Product T cell therapy
  Product 2 investment banking
Index terms Index term Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds
  Index term 2 Trianta Immunotherapies–Medigene: investment, 201401 acquisition 100% for 1m shares worth €4m plus €5.875m milestones in shares or cash

Record changed: 2017-04-02


Picture [iito] – Putting Information into Context 600x102px

More documents for Medigene (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top